Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» agenT-797
agenT-797
First patient dosed with AgenTus’ cell therapy designed to clear COVID-19 virus while reducing inflammation
Biopharma Reporter
Mon, 11/9/20 - 11:09 am
Agenus
cell therapy
agenT-797
COVID-19
clinical trials